Allergic Conjunctivitis Market By Disease Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Allergic Conjunctivitis Market
Allergic Conjunctivitis Market: By Disease Type, By Treatment Type & Geography-Forecast (2016-2021)
Report Code : HCR 0110
Updated Date: 07 March, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Global Allergic Conjunctivitis Market – Market Overview
2. Executive Summary
Global Allergic Conjunctivitis Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Global Allergic Conjunctivitis Market – Market Forces
   4.1. Drivers
      4.1.1. Developing medical infrastructure in emerging economies
      4.1.2. Increasing awareness amongst people
   4.2. Restraints
      4.2.1. High cost for developing & testing the treatment
   4.3. Opportunities
      4.3.1. Developing an allergy specific treatment
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Global Allergic Conjunctivitis Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Allergic Conjunctivitis Market - By Disease Type
   6.1. Seasonal Allergic Conjunctivitis
   6.2. Perennial Allergic Conjunctivitis
   6.3. Giant Papillary Conjunctivitis
   6.4. Vernal Kerato Conjunctivitis
   6.5. Atopic Kerato Conjunctivitis
7. Global Allergic Conjunctivitis Market - By Treatment Type 
   7.1. Antihistamines
   7.2. Mast Cell Stabilizers
   7.3. Olopatadine
   7.4. Epinastine
   7.5. Nonsteroidal Anti-Inflammatory Drugs
   7.6. Others
8. Global Allergic Conjunctivitis Market - By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Allergic Conjunctivitis – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions, and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Aciex Therapeutics
      10.1.1.  Introduction
      10.1.2. Financials
      10.1.3. Key Insights
      10.1.4. Key Strategy
      10.1.5. Product Portfolio
      10.1.6. SWOT Analysis
   10.2. Alcon/Novartis
      10.2.1. Introduction
      10.2.2. Financials
      10.2.3. Key Insights
      10.2.4. Key Strategy
      10.2.5. Product Portfolio
      10.2.6. SWOT Analysis
   10.3. Allergan
      10.3.1.  Introduction
      10.3.2. Financials
      10.3.3. Key Insights
      10.3.4. Key Strategy
      10.3.5. Product Portfolio
      10.3.6. SWOT Analysis
   10.4. Sun Pharma Advanced Research Company Ocular Therapeutix
      10.4.1. Introduction
      10.4.2. Financials
      10.4.3. Key Insights
      10.4.4. Key Strategy
      10.4.5. Product Portfolio
      10.4.6. SWOT Analysis
   10.5. Sirion Therapeutics
      10.5.1. Introduction
      10.5.2. Financials
      10.5.3. Key Insights
      10.5.4. Key Strategy
      10.5.5. Product Portfolio
      10.5.6. SWOT Analysis
   10.6. Boehringer Ingelheim
      10.6.1. Introduction
      10.6.2. Financials
      10.6.3. Key Insights
      10.6.4. Key Strategy
      10.6.5. Product Portfolio
      10.6.6. SWOT Analysis
   10.7. Atopix Therapeutics
      10.7.1. Introduction
      10.7.2. Financials
      10.7.3. Key Insights
      10.7.4. Key Strategy
      10.7.5. Product Portfolio
      10.7.6. SWOT Analysis
   10.8. Laila Pharmaceuticals
      10.8.1. Introduction
      10.8.2. Financials
      10.8.3. Key Insights
      10.8.4. Key Strategy
      10.8.5. Product Portfolio
      10.8.6. SWOT Analysis
   10.9. Laboratoires Thea S.A.
      10.9.1. Introduction
      10.9.2. Financials
      10.9.3. Key Insights
      10.9.4. Key Strategy
      10.9.5. Product Portfolio
      10.9.6. SWOT Analysis
   10.10. Auven Therapeutics
      10.10.1. Introduction
      10.10.2. Financials
      10.10.3. Key Insights
      10.10.4. Key Strategy
      10.10.5. Product Portfolio
      10.10.6. SWOT Analysis
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Allergic conjunctivitis is defined as inflammation conjunctive in the eye caused due to an allergic reaction to substances like pollen, household dust, animal dander and mold spores especially during hay season. This disease is characterised by some of the common symptoms such as red, itchy, watery, and burning eyes are common symptoms of allergic conjunctivitis or puffy eyes in the morning. Globally increasing awareness amongst people about the disease and developing medical infrastructure in emerging economies providing easy access to the treatment for Allergic conjunctivitis treatments.

This report identifies the Allergic conjunctivitis market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Allergic conjunctivitis treatment market.

Allergic Conjunctivitis Market

North America is the largest market owing to the high prevalence of allergic conjunctivitis in the region. North American allergic conjunctivitis treatment market is followed by Europe and Asia-Pacific as the second and third largest regional market respectively. Demand for the allergic conjunctivitis treatment is expected to grow the fastest in the Asia Pacific region due to increasing medical infrastructure in the region making easy access for the treatments and also rapid urbanization and increasing pollution has resulted into higher cases for allergic conjunctivitis in the several regional countries.

This report segments global Allergic conjunctivitis treatment market on the basis of disease type, treatment type and regional market as follows:
  • This report on global allergic Conjunctivitis market also covers major disease type of allergice conjunctivitis including: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis, Giant Papillary Conjunctivitis, Vernal Kerato Conjunctivitis, Atopic Kerato Conjunctivitis
  • On the basis of current available treatments global allergic conjunctivitis market is segmented as follows: Antihistamines, Mast Cell Stabilizers, Olopatadine, Epinastine, Nonsteroidal Anti-Inflammatory Drugs and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets for allergic conjunctivitis in each of the region.

Sample Companies Profiled in this Report are: 

  • Aciex Therapeutics
  • Alcon/Novartis
  • Sun Pharma Advanced Research Company Ocular Therapeutix
  • Sirion Therapeutics
  • Boehringer Ingelheim
  • 10+
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports